{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:38:04Z","timestamp":1762317484241,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.eplepsyres.2025.107611","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:26:55Z","timestamp":1749320815000},"page":"107611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Latent renal tubular dysfunction in patients with epilepsy treated with valproic acid"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3169-1169","authenticated-orcid":false,"given":"Fumi","family":"Sawamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2081-9449","authenticated-orcid":false,"given":"Jun","family":"Natsume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Mitsumatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motomasa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kidokoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2025.107611_bib1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s004670000535","article-title":"Renal tubular dysfunction in epileptic children on valproic acid therapy","volume":"16","author":"Altunba\u015fak","year":"2001","journal-title":"Pedia Nephrol."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib2","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00467-022-05869-8","article-title":"Kidney tubular injury induced by valproic acid: systematic literature review","volume":"38","author":"Anguissola","year":"2023","journal-title":"Pedia Nephrol."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0002-9343(88)90055-1","article-title":"Side effects of valproate","volume":"84","author":"Dreifuss","year":"1988","journal-title":"Am. J. Med"},{"key":"10.1016\/j.eplepsyres.2025.107611_bib4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav. Res Methods"},{"key":"10.1016\/j.eplepsyres.2025.107611_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res Methods"},{"key":"10.1016\/j.eplepsyres.2025.107611_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0883073814538505","article-title":"Does nephrotoxicity exist in pediatric epileptic patients on valproate or carbamazepine therapy?","volume":"30","author":"Havali","year":"2015","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/ped.12470","article-title":"The ratios of urinary \u03b22-microglobulin and NAG to creatinine vary with age in children","volume":"57","author":"Hibi","year":"2015","journal-title":"Pedia Int."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1442-200X.1990.tb00799.x","article-title":"Secondary carnitine deficiency in handicapped patients receiving valproic acid and\/or elemental diet","volume":"32","author":"Igarashi","year":"1990","journal-title":"Acta Paediatr. Jpn."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00467-013-2512-x","article-title":"The effects of sodium valproate on the renal function of children with epilepsy","volume":"29","author":"Knights","year":"2014","journal-title":"Pedia Nephrol."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.0013-9580.2004.05504.x","article-title":"Fanconi syndrome caused by antiepileptic therapy with valproic acid","volume":"45","author":"Knorr","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107611_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpeds.2016.02.080","article-title":"Clinical features of carnitine deficiency secondary to pivalate-conjugated antibiotic therapy","volume":"173","author":"Kobayashi","year":"2016","journal-title":"J. Pedia"},{"key":"10.1016\/j.eplepsyres.2025.107611_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s10157-017-1472-z","article-title":"Risk factors for sodium valproate-induced renal tubular dysfunction","volume":"22","author":"Koga","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/ejpn.2000.0378","article-title":"Increased urinary excretion of tubular enzymes and proteins in children with epilepsy","volume":"4","author":"Korinthenberg","year":"2000","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib14","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s11845-023-03296-8","article-title":"Normal values for pediatric urinary biochemistry in early infancy","volume":"192","author":"Ohta","year":"2023","journal-title":"Ir. J. Med Sci."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s10157-018-1581-3","article-title":"Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation","volume":"23","author":"Ono","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review","volume":"31","author":"Silva","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pediatrneurol.2022.03.001","article-title":"Fanconi syndrome secondary to sodium valproate therapy: experience and literature review","volume":"130","author":"Sturla \u00c1lvarez","year":"2022","journal-title":"Pedia Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10157-017-1436-3","article-title":"Urinary biomarkers in the early detection and follow-up of tubular injury in childhood urolithiasis","volume":"22","author":"Ta\u015fdemir","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1440-1797.2006.00699.x","article-title":"Evaluation of renal tubular function in children taking anti-epileptic treatment","volume":"11","author":"Unay","year":"2006","journal-title":"Nephrology"},{"key":"10.1016\/j.eplepsyres.2025.107611_bib20","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1528-1157.2000.tb00118.x","article-title":"Renal tubular function in patients receiving anticonvulsant therapy: a long-term study","volume":"41","author":"Verrotti","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107611_bib21","article-title":"Valproic-induced Fanconi syndrome: Clinical features, risk factors, diagnosis and management","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib22","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00467-005-1827-7","article-title":"Secondary renal Fanconi syndrome caused by valproate therapy","volume":"20","author":"Watanabe","year":"2005","journal-title":"Pedia Nephrol."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/ped.12956","article-title":"Outcome of renal proximal tubular dysfunction with Fanconi syndrome caused by sodium valproate","volume":"58","author":"Yamazaki","year":"2016","journal-title":"Pedia Int."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0387-7604(02)00210-3","article-title":"Hypouricemia in severely disabled children: influence of valproic acid and bed-ridden state","volume":"25","author":"Yoshikawa","year":"2003","journal-title":"Brain Dev."},{"key":"10.1016\/j.eplepsyres.2025.107611_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0887-8994(98)00079-4","article-title":"N-acetyl-beta-glucosaminidase and beta-galactosidase activity in children receiving antiepileptic drugs","volume":"20","author":"Y\u00fcksel","year":"1999","journal-title":"Pedia Neurol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:34:33Z","timestamp":1762317273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121125001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":25,"alternative-id":["S0920121125001123"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107611","relation":{},"ISSN":["0920-1211"],"issn-type":[{"type":"print","value":"0920-1211"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latent renal tubular dysfunction in patients with epilepsy treated with valproic acid","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107611"}}